P3 Health Partners (NASDAQ:PIII) reported second-quarter adjusted EBITDA of $54 million and raised its full-year 2026 outlook, while noting that the quarterly result included $45 million of favorable payer settlements and prior-year development.
Chief Executive Officer Aric Coffman said the company
Gainers P3 Health Partners (NASDAQ:PIII) shares increased by 24.1% to $15.92 during Monday's after-market session. The market value of their outstanding shares is at $38.5 million. As per the press release, Q2
P3 Health Partners (PIII) Q2 2025 earnings miss estimates with $355.8M revenue, but shares rise 7.3% on cost control optimism. Targets 2026 profitability.
